Among cancers in which KRAS mutations predominate, including pancreatic ductal adenocarcinomas (PDA), lung adenocarcinomas (LAC), and colorectal carcinomas (CRC), over 75% of amino acid substitutions occur at the G12 codon position4. Here, KRAS is linked to cancer.